Literature DB >> 19553607

Test-retest reliability of saccadic measures in subjects at risk for Huntington disease.

Tanya Blekher1, Marjorie R Weaver, Xueya Cai, Siu Hui, Jeanine Marshall, Jacqueline Gray Jackson, Joanne Wojcieszek, Robert D Yee, Tatiana M Foroud.   

Abstract

PURPOSE: Abnormalities in saccades appear to be sensitive and specific biomarkers in the prediagnostic stages of Huntington disease (HD). The goal of this study was to evaluate test-retest reliability of saccadic measures in prediagnostic carriers of the HD gene expansion (PDHD) and normal controls (NC).
METHODS: The study sample included 9 PDHD and 12 NC who completed two study visits within an approximate 1-month interval. At the first visit, all participants completed a uniform clinical evaluation. A high-resolution, video-based system was used to record eye movements during completion of a battery of visually guided, antisaccade, and memory-guided tasks. Latency, velocity, gain, and percentage of errors were quantified. Test-retest reliability was estimated by calculating the intraclass correlation (ICC) of the saccade measures collected at the first and second visits. In addition, an equality test based on Fisher's z-transformation was used to evaluate the effects of group (PDHD and NC) and the subject's sex on ICC.
RESULTS: The percentage of errors showed moderate to high reliability in the antisaccade and memory-guided tasks (ICC = 0.64-0.93). The latency of the saccades also demonstrated moderate to high reliability (ICC = 0.55-0.87) across all tasks. The velocity and gain of the saccades showed moderate reliability. The ICC was similar in the PDHD and NC groups. There was no significant effect of sex on the ICC.
CONCLUSIONS: Good reliability of saccadic latency and percentage of errors in both antisaccade and memory-guided tasks suggests that these measures could serve as biomarkers to evaluate progression in HD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553607     DOI: 10.1167/iovs.09-3538

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Huntington's disease: changes in saccades and hand-tapping over 3 years.

Authors:  Chrystalina A Antoniades; Zheyu Xu; Sarah L Mason; R H S Carpenter; Roger A Barker
Journal:  J Neurol       Date:  2010-06-29       Impact factor: 4.849

2.  Preclinical assessment of CNS drug action using eye movements in mice.

Authors:  Hugh Cahill; Amir Rattner; Jeremy Nathans
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

3.  Comparison of vertical and horizontal saccade measures and their relation to gray matter changes in premanifest and manifest Huntington disease.

Authors:  Jason Rupp; Mario Dzemidzic; Tanya Blekher; John West; Siu Hui; Joanne Wojcieszek; Andrew J Saykin; David A Kareken; Tatiana Foroud
Journal:  J Neurol       Date:  2011-08-18       Impact factor: 4.849

Review 4.  Eye movements in patients with neurodegenerative disorders.

Authors:  Tim J Anderson; Michael R MacAskill
Journal:  Nat Rev Neurol       Date:  2013-01-22       Impact factor: 42.937

5.  Basic and translational neuro-ophthalmology of visually guided saccades: disorders of velocity.

Authors:  Sushant Puri; Aasef G Shaikh
Journal:  Expert Rev Ophthalmol       Date:  2017-11-28

6.  Temporal stability and the effects of training on saccade latency in "express saccade makers".

Authors:  Paul C Knox; Felicity D A Wolohan
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

7.  Aging Effects and Test-Retest Reliability of Inhibitory Control for Saccadic Eye Movements.

Authors:  Martyna Beata Płomecka; Zofia Barańczuk-Turska; Christian Pfeiffer; Nicolas Langer
Journal:  eNeuro       Date:  2020-09-29

8.  Behavioral and Neural Plasticity of Ocular Motor Control: Changes in Performance and fMRI Activity Following Antisaccade Training.

Authors:  Sharna D Jamadar; Beth P Johnson; Meaghan Clough; Gary F Egan; Joanne Fielding
Journal:  Front Hum Neurosci       Date:  2015-12-18       Impact factor: 3.169

9.  A Computational Cognitive Biomarker for Early-Stage Huntington's Disease.

Authors:  Thomas V Wiecki; Chrystalina A Antoniades; Alexander Stevenson; Christopher Kennard; Beth Borowsky; Gail Owen; Blair Leavitt; Raymund Roos; Alexandra Durr; Sarah J Tabrizi; Michael J Frank
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

10.  A standardized protocol for quantification of saccadic eye movements: DEMoNS.

Authors:  J A Nij Bijvank; A Petzold; L J Balk; H S Tan; B M J Uitdehaag; M Theodorou; L J van Rijn
Journal:  PLoS One       Date:  2018-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.